195 related articles for article (PubMed ID: 34391759)
1. Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India.
Ganesan G; Ponniah S; Sundaram V; Marimuthu PK; Pitchaikannu V; Chandrasekaran M; Thangarasu J; Kannupaiyan G; Ramamoorthy P; Thangaraj B; Shree Vaishnavi R
Radiother Oncol; 2021 Oct; 163():83-90. PubMed ID: 34391759
[TBL] [Abstract][Full Text] [Related]
2. Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial).
Ganesan G; Ponniah S; Sundaram V; Marimuthu PK; Pitchaikannu V; Chandrasekaran M; Thangarasu J; Kannupaiyan G; Ramamoorthy P; Thangaraj B; Govindaraj HS; Raguram SV
Radiother Oncol; 2022 Feb; 167():133-142. PubMed ID: 34958809
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
4. A pilot phase Ib/II study of whole-lung low dose radiation therapy (LDRT) for the treatment of severe COVID-19 pneumonia: First experience from Africa.
Saleh M; Sharma K; Shah J; Karsan F; Waweru A; Musumbi M; Shah R; Sayed S; Abayo I; Karimi N; Gondi S; Rupani S; Kirathe G; Amariati H
PLoS One; 2022; 17(7):e0270594. PubMed ID: 35776736
[TBL] [Abstract][Full Text] [Related]
5. Interim Analysis of Impact of Adding Low Dose Pulmonary Radiotherapy to Moderate COVID-19 Pneumonia Patients: IMpaCt-RT Study.
Singh P; Mandal A; Singh D; Kumar S; Kumar A; Rakesh A; Ranjan R; Verma M; Rai DK; Bhushan D; Shankar A; Sinha A; Saini R; Saha A; Thovarayi A; Baral AK; Chauhan S; Kumar R; Kakoty P; Modak B; Ranjan A
Front Oncol; 2022; 12():822902. PubMed ID: 35425707
[TBL] [Abstract][Full Text] [Related]
6. Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).
Arenas M; Algara M; De Febrer G; Rubio C; Sanz X; de la Casa MA; Vasco C; Marín J; Fernández-Letón P; Villar J; Torres-Royo L; Villares P; Membrive I; Acosta J; López-Cano M; Araguas P; Quera J; Rodríguez-Tomás F; Montero A
Strahlenther Onkol; 2021 Nov; 197(11):1010-1020. PubMed ID: 34230996
[TBL] [Abstract][Full Text] [Related]
7. Low-dose whole-lung radiation for COVID-19 pneumonia: Planned day 7 interim analysis of a registered clinical trial.
Hess CB; Buchwald ZS; Stokes W; Nasti TH; Switchenko JM; Weinberg BD; Steinberg JP; Godette KD; Murphy D; Ahmed R; Curran WJ; Khan MK
Cancer; 2020 Dec; 126(23):5109-5113. PubMed ID: 32986274
[TBL] [Abstract][Full Text] [Related]
8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
9. Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial.
Declercq J; Bosteels C; Van Damme K; De Leeuw E; Maes B; Vandecauter A; Vermeersch S; Delporte A; Demeyere B; Vuylsteke M; Lalla M; Smart T; Detalle L; Bouw R; Streffer J; Degeeter T; Vergotte M; Guisez T; Van Braeckel E; Van Der Straeten C; Lambrecht BN
Trials; 2020 Nov; 21(1):934. PubMed ID: 33213529
[TBL] [Abstract][Full Text] [Related]
10. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with Coronavirus Disease 2019-Related Pneumonia.
Hess CB; Nasti TH; Dhere VR; Kleber TJ; Switchenko JM; Buchwald ZS; Stokes WA; Weinberg BD; Rouphael N; Steinberg JP; Godette KD; Murphy DJ; Ahmed R; Curran WJ; Khan MK
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(4):867-879. PubMed ID: 33340603
[TBL] [Abstract][Full Text] [Related]
12. Low-dose radiation therapy for COVID-19 pneumonia: a pilot study.
Sharma DN; Guleria R; Wig N; Mohan A; Rath G; Subramani V; Bhatnagar S; Mallick S; Sharma A; Patil P; Madan K; Soneja M; Thulkar S; Singh A; Singh S
Br J Radiol; 2021 Oct; 94(1126):20210187. PubMed ID: 34545760
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of low-dose lung radiotherapy in the management of COVID-19 patients: a randomised, open-label study.
Dinakar K; Jakka MK; Vemannagari PKR; Mohan A; Subramanian BV; Bodagala VD; Bhuma V; Das P; Bonala SR; Vutukuru VR
Br J Radiol; 2023 Dec; 96(1152):20230022. PubMed ID: 37751170
[TBL] [Abstract][Full Text] [Related]
14. Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial.
Chowdhury FR; Hoque A; Chowdhury FUH; Amin MR; Rahim A; Rahman MM; Yasmin R; Amin MR; Miah MT; Kalam MA; Rahman MS
Trials; 2020 Oct; 21(1):883. PubMed ID: 33106167
[TBL] [Abstract][Full Text] [Related]
15. Low-Dose Radiotherapy for Patients with Pneumonia Due to COVID-19: A Single-Institution Prospective Study.
Rutkowski TW; Jaroszewicz J; Piotrowski D; Ślosarek K; Sobala-Szczygieł B; Słonina D; Włostowska B; Bodusz D; Piasecki M; Nachlik M; Oczko-Grzesik B; Gądek A; Kowal D; Rutkowski R; Wojarska-Tręda E; Składowski K
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979837
[TBL] [Abstract][Full Text] [Related]
16. Low-dose Lung Radiotherapy for COVID-19-related Pneumonia: Preliminary Results of the Italian Mono-institutional COLOR-19 Trial.
Magrini SM; Tomasini D; Focà E; Garrafa EM; Singh N; Guerini AE; Triggiani L; Bresciani R; Greco D; Pegurri L; LA Mattina S; Ranghetti E; Volpi G; Maroldi R; Buglione M; Spiazzi L
In Vivo; 2022; 36(4):1959-1965. PubMed ID: 35738608
[TBL] [Abstract][Full Text] [Related]
17. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 activation putatively mediates clinical benefits of low-dose radiotherapy in COVID-19 pneumonia and acute respiratory distress syndrome (ARDS): Novel mechanistic considerations.
Calabrese EJ; Kozumbo WJ; Kapoor R; Dhawan G; Lara PC; Giordano J
Radiother Oncol; 2021 Jul; 160():125-131. PubMed ID: 33932453
[TBL] [Abstract][Full Text] [Related]
19. Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia: A Randomized Double-Blind Study.
Papachristofilou A; Finazzi T; Blum A; Zehnder T; Zellweger N; Lustenberger J; Bauer T; Dott C; Avcu Y; Kohler G; Zimmermann F; Pargger H; Siegemund M
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1274-1282. PubMed ID: 33677049
[TBL] [Abstract][Full Text] [Related]
20. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
